UK weight-loss care: four nations, different routes

England combines national recommendations with ICB-led implementation and phased primary-care access. Our Mounjaro NHS guide explains the 2026 cohorts. Your GP or ICB confirms the service currently accepting referrals.

When checking an update, distinguish a national announcement from an operational local page. Note the publication date and whether it describes future plans or a route available now.

The Scottish Medicines Consortium accepted tirzepatide for restricted NHS use in adults with BMI at least 30 and a weight-related comorbidity, with appropriate lower thresholds for some ethnic groups. That recommendation differs from England’s rollout cohorts. It does not confirm that an individual health-board pathway offers immediate access.

Check your board’s patient information and discuss the referral with your care team. NHS Fife’s medicine information illustrates why local delivery needs a separate check.

The Welsh circular updated in July 2026 generally places interim prescribing within specialist weight-management services. It also describes defined urgent clinical exceptions and approved pathway innovations. The responsible clinical service must take prescribing responsibility. The earlier WHC/2025/018 circular has been superseded.

A clinician should assess whether a specific exception applies. Do not import an English cohort threshold into a Welsh referral or assume that a short description of an exception is enough to qualify.

The Department of Health announced a first phase of its Regional Obesity Management Service in June 2026, planned for early autumn and focused on highest clinical need. This review did not verify an operational October referral route. An announcement is not confirmation that a particular clinic is accepting referrals.

Ask your GP or current Health and Social Care service for the live position. Avoid relying on an old statement that no service exists, or on a planned launch date as a guarantee that treatment can be booked.

Write down the nation, responsible local organisation, publication date, named pathway and contact route. Then separate three things: clinical criteria, service availability and referral instructions. If one is missing, ask for it before assuming the pathway applies to you.

This is also useful when moving home or changing GP. Tell the relevant teams about current treatment and ask how records and monitoring will transfer. Continuity needs an agreed plan, not simply a new address.